ognizant Communication Corporation

ONCOLOGY RESEARCH

AUTHOR AND SUBJECT INDEXES

VOLUME 12

Author Index

Akutsu, H., 255
Akutsu, M., 137
Andrei, G., 397
Ansell, J., 281, 282, 283, 297
Antzaklis, A. I., 287, 288
Avivi-Green, C., 83
Avner, P., 292
Azare, J., 315

Backus, H. H. J., 231
Bae, D. K., 5
Baguley, B. C., 149
Baird, J., 297
Bando, M., 173
Banerjee, D., 309
Bartel, F., 451
Baxevanis, C. N., 287, 288
Bermudes, D., 127, 501
Bertino, J. R., 11, 309
Bialik, S., 262
Bie, W., 294
Bishop, J. M., 263
Blank, M., 409
Bloomer, W. D., 185, 325
Boller, Y. C., 383
Borselli, C., 347
Brandes, L. M., 383
Brown, K. W., 441
Brunk, B., 270

Caciagli, B., 361
Cacoullos, N. T., 287
Cambray, N., 297
Carmen, M., 11
Carotti, S., 361
Castagnetti, G., 43
Cesinaro, A. M., 43
Chang, C. C., 277
Chang, R. L., 419
Changeux, J.-P., 292
Charest, A., 275
Charters, G. A., 149
Chen, G., 59
Chen, J., 501
Chevassut, T., 280, 281
Chi, S. G., 5
Chiarugi, V., 1
Claret, F.-X., 291, 295
Clarke, A. R., 264
Cohen, D., 315
Collard, G. J., 260
Conney, A. H., 419
Coronnello, M., 361
Cui, X.-X., 419

Dabelsteen, S., 289
D'Armiento, M. R., 347
De Bari, C., 284
De Clercq, E., 397
De Gaetani, C., 43
De Vincenzo, R., 355
Dell'Accio, F., 284
Deng, H., 278
Derry, J. J., 294
Desponts, C., 285
Dilley, R. J., 193
Distefano, M., 355
Dotti, A., 43
Dréau, D., 241
Dube, S. K., 11
Dumont, J. E., 347
Dvorak, P., 299
Dvorakova, D., 299
Dzierzak, E., 258

Eggan, K., 255
El-Gewely, M. R., 304
Erhardt, S., 256
Ernst, R., 270

Felsher, D., 263
Feng, M., 127
Ferlini, C., 355, 429
Ferrandina, G., 429
Ferrari, G., 43
Ferrari, P., 43
Fidler, I. J., 97
Filippini, P., 429
Flescher, E., 315
Fodstad, Ø., 113
Foley, J., 71
Forrester, L., 281, 282, 297
Foster, M., 241
Freedman, R. S., 429
Fruscella, E., 429
Fukushima, S., 121
Furukawa, Y., 137, 469
Furuse, M., 469
Fusco, A., 347

Gaggini, C., 355
Gallimore, P. H., 298
Garcia, A. M., 477
Gartel, A. L., 293
Gatter, K. C., 33, 203
Georgoulias, V. A., 33, 203
Gerbasio, D., 347
Ghansah, T., 285
Giatromanolaki, A., 33, 203
Gika, D. G., 287
Gorbea, C., 298
Gorlick, R., 309
Goufman, E., 293
Grabarek, J. B., 286
Graham, G., 297
Grand, R. J. A., 298
Gritzapis, A. D., 287
Gurdon, J. B., 253

Hackney, J., 270
Hampl, A., 299
Han, Z. T., 419
Hanibuchi, M., 173, 209
Harris, A. L., 33, 203
Harris, L. C., 451
Hay, N., 293
Hochedlinger, K., 255
Hogg, M., 241
Holdaway, K. M., 149
Holder, W. D., 241
Hollis, K., 294
Honda, H., 270
Hosono, M., 121
Housman, D., 275
Howson, J., 285
Huang, T. H.-M., 441
Huncharek, M., 107
Hurley, J. H., 302

Ide, S., 296
Iijima, R., 51
Ikuta, Y., 25
Inbal, B., 262
Ioannidis, P., 288
Ishiguro, T., 181, 343
Ishihara, H., 477
Ittensohn, M., 127, 501
Ivanova, N., 270
Iwakura, Y., 121
Izzo, J., 309

Jackson, M., 282, 297
Jaenisch, R., 255
Jansen, G., 231
Jhanwar, S. C., 309
Ji, M., 185, 325
Jiménez, J. A., 71

Kajiwara, M., 17
Kaklamanis, L. G., 203
Kakolyris, S. A., 33, 203
Kano, Y., 137
Kapsoritakis, A., 33
Karasiewicz, J., 286
Kavalakis, J. G., 287, 288
Kawakami, K., 459
Kawakami, M., 459
Keisari, Y., 409
Keller, G., 259
Kelly, K. A., 419
Kennedy, K. A., 383
Kennedy, M., 259
Kerr, W. G., 285
Kheifets, V., 275
Kimchi, A., 262
King, C. S., 71
King, I. C., 127, 501
Kittappa, R., 270
Koezuka, Y., 51
Komatsu, F., 17, 371
Koukourakis, M. I., 33
Koukourakis, M. J., 203
Kowalczyk, J. J., 477
Krassowska, A., 283
Kraus, M., 278
Kuiper, C. M., 231
Kupelnick, B., 107

Lai, P. B. S., 59
Lane, K., 275
Lau, W., 59
Lavie, G., 409
Lawrence D. S., 219
Lazo, J. S., 274
Le Novère, N., 292
Le, T., 127, 501
Ledent, C., 347
Lee, C. W., 5
Leet, C. S. F., 193
Lehrach, H., 269
Leland, P., 459
Lemischka, I., 270
Leung, B. C. S., 59
Leung, M., 59
Leung, T. W. T., 59
Lewis, M. D., 477
Li, E., 282
Li, Z., 127, 501
Liew, C., 59
Lim, B., 261, 280, 281
Lim, S.-K., 279
Lim, Y. K., 279
Lin, H.-Y., 270
Lin, S. L., 127, 501
Lin, Y., 419
Lin, Z. P., 383
Liu, H., 278
Liu, L., 278
Lodie, T. A., 266
Loi, T. H., 300
Longo, G. S. A., 309
Lorico, A., 113
Lun, Y., 270
Luo, X., 127, 501
Luyten, F. P., 284

Ma, D. D. F., 300
Madar, Z., 83
Maggiano, N., 429
Magnelli, L., 1
Makino, S., 121
Malik, K., 441
Mancuso, S., 355, 429
Mandel, M., 409
Mansouri, A., 291, 295
Marcon, G., 361
Marshall, E. S., 149
Masuda, T., 371
Matushansky, I., 272
May, S. L., 285
Mayer, J., 299
Mazzei, T., 361
McKay, R., 267
McMahon, K., 275
Medvinsky, A., 283
Messori, L., 361
Migaldi, M., 43
Miki, K., 335
Miki, T., 209
Mini, E., 361
Miwa, N., 469
Modlinski, J. A., 286
Molotkov, A., 169
Moore, K., 270
Mori, S., 121
Motoki, K., 51
Mozzetti, S., 429
Mulligan, R. C., 268
Murai, T., 121
Murakami, T., 25
Myers, C. B., 219
Mymryk, J. S., 298

Nagasu, T., 477
Nagawa, H., 181, 343
Najmabadi, F., 293
Nakagawa, R., 51
Nakamura, H., 51
Nakamura, K., 477
Nakamura, Y., 469
Namiki, M., 477
Neys, J., 284
Ng, S. C., 279
Nguyen, K. H. T., 285
Niikawa, N., 469
Ninos, J. M., 285
Nishioka, Y., 173
Nitta, Y., 25

Olsen, J., 289
Oohara, T., 121
Orioli, P., 361
Ouzounis, C., 271
Overton, C., 270

Pabst, T., 266
Palis, J., 259
Pampalakis, G., 290
Pankova-Kholmyansky, I., 315
Papadopoulou, L., 273
Papadopoulou, M. V., 185, 325
Papalexi, E. A., 287, 288
Papamichail, M., 287, 288
Pappas, I., 273
Parajuli, P., 173
Park, J., 275
Park, Y.-K., 5
Parmar, J., 149
Paspatis, G., 33
Patierno, S. R., 383
Pelletier, J., 275
Perez, S. A., 287, 288
Peters, G. J., 231
Philbrick, W. M., 71
Phillips, R., 270
Phillips, W. A., 193
Pinedo, H. M., 231
Plusa, B., 286
Polak-Charcon, S., 83
Polymeropoulos, M., 296
Portella, G., 347
Pritzker, M., 270
Puri, R. K., 459

Röpke, A., 491
Rabbitts, T., 265
Rabson, A., 419
Radomska, H. S., 266
Radparvar, F., 272
Ramsahoye, B., 282
Ranelletti, F. O., 429
Rao, M. K., 185, 325
Rappa, G., 113
Rassidakis, G. Z., 295
Raveh, T., 262
Rayburn, H., 275
Rede, T., 300
Refaeli, Y., 263
Reiss, M., 157
Reppa, D. K., 203
Reyes, N. I., 193
Richard, S., 294
Rideout, W. M. III, 255
Rider, K., 278
Ridgway, L. D., 291, 295
Rogner, U. C., 292
Rothstein, J. L., 347
Rousomoustakaki, M., 203
Ruggiero, M., 1
Runyab, J. D., 501
Russell, R. L., 383

Saitou, M., 256
Salnikow, K., 315
Salto-Tellez, M., 279
Samuel, K., 283
Santoro, M., 347
Sartorelli, A. C., 113
Sato, M., 51
Satoh, M., 169
Scambia, G., 355, 429
Schols, D., 397
Schwartz, B., 83
Sell, C., 491
Serizawa, I., 51
Shani, G., 262
Shelling, A. N., 149
Shen, S., 501
Shianov, P., 293
Shih, W. J., 419
Shimizu, E., 335
Shimosaka, A., 51
Shoat, G., 262
Shyam, K., 113
Sidiropoulou, A., 273
Simillides, G., 290
Sivridis, E., 33
Skoultchi, A. I., 272
Smith, C. D., 219
Smith, S. N., 219
Snoeck, H.-W., 301
Snoeck, R., 397
Sone, S., 173, 209, 335
Sotiropoulou, G., 290
Sotiropoulou, P. A., 287, 288
Souglakos, J. C., 203
Spivak, T., 262
Spyropoulos, D., 292
Srimatkandada, S., 11
Stanier, P., 292
Stathopoulos, G. P., 33
Stevens, Z., 278
Stoeckert, C., 270
Stoler, A. B., 429
Strair, R., 419
Stumm, M., 491
Sugita, T., 25
Suh, J., 419
Surani, M. A., 256
Suzuki, K., 137
Swiggett, J., 241

Takashima, A., 121
Takeda, R., 121
Tani, K., 335
Taubert, H., 451
Taylor, A. C., 451
Tenen, D. G., 266
Thomas, R. J. S., 193
Thomson, I., 283
Tiang, L., 295
Tohyama, C., 169
Trailsmith, M., 127
Trentini, G. P., 43
Troelsen, J. T., 289
Trosko, J. E., 277
Trumpp, A., 263
Tsetsenis, T., 290
Tsiftsoglou, A. S., 273, 296
Tsujishita, Y., 302
Tsukita, S., 469
Tsunoda, S., 137
Turnell, A. S., 298
Tyner, A. L., 293, 294

Ueno, H., 51
Unni, K. K., 5

van Groeningen, C. J., 231
Vanosdol, M., 278
Vecchio, G., 347
Vellucci, V. F., 157
Vincan, E., 193
Vizirianakis, I., 273

Wakayama, T., 257
Wang, J.-W., 285
Weidle, U. H., 491
Western, P., 256
White, R. L., 241
Wieacker, P. F., 491
Wieland, I., 491
Wilmut, I., 254
Wong, N., 59
Wouters, D., 231
Wysolmerski, J. J., 71

Xu, H., 304
Xu, L., 97
Xu, Y., 485

Yamaguchi, A., 477
Yan, P., 441
Yan, W., 157
Yanagawa, H., 173
Yanagimachi, R., 255
Yano, S., 173, 209, 335
Yaspo, M.-L., 303
Yazawa, Y., 137
Ye, X., 293
Yin, Y., 279
Ying, H., 485
Yoshimatsu, K., 477
Yu, Y., 485

Zeicher, M., 305
Zhang, P., 266
Zhang, Q., 291, 295
Zhang, X., 298
Zheng, L., 127, 501
Zheng, X., 419
Zilfou, J. T., 219
 
 

Subject Index

Adenocarcinoma, 309
Adhesion molecules, 17, 459
AG337, 231
Angiogenesis, 1, 33, 203
Antagonism, 355
Antibody, 241
Antifolate, 309
Antitumor effect, 501
Apoptosis, 83, 231, 315, 371, 397
ATF3 gene, 181, 343
ATP synthase subunit e, 485
Autocrine growth factor, 97
Autophagic cell death, 371
5-aza-2´-deoxycitidine (5-azadC), 335

Basic fibroblast growth factor, 241
bcl-2, 43
Bioreductive drug(s), 185, 325
Cancer, 127, 193, 219
b-Catenin, 193, 469

CD20, 241
cDNA microarray analysis, 59
Cell-cell adhesion-independent killing, 371
Cell cycle, 355
Cell form, 343
Cell migration, 343
Ceramide, 315
Cervical cancer, 429
Claudin-1, 469
Clinical epidemiology, 107
Clotting factors, 1
Coamplification, 11
Colon, 193, 231
Colon cancer, 83, 469
Colorectal, 309
Colorectal cancer, 203
COMET assay, 361
Cytokines, 409
Cytotoxicity, 361

DEAD box, 491
Delivery, 127
Differential display, 485
Differentiation, 193, 419
Dihydrofolate reductase, 11
DNA damage, 231
DNA sequencing, 149
Drug combination, 137
Drug efflux, 113
Drug resistance, 219, 383

E7 oncogene, 347
Ehrlich ascites carcinoma, 169
Endothelial cell polarity, 1
Epigenetics, 441
Epithelium, 193
ER-51785, 477
Etoposide, 383

Farnesyl transferase, 477
Fatty aromatic acids, 429
Flow cytometry, 149, 361
5-Fluorouracil, 137, 231

Gain of function, 71
a-Galactosylceramide, 51
Ganglioside GM2, 173
Gastric cancer, 33
Gemcitabine, 355
Gene amplification, 107
Gene expression, 59, 181
Genomics, 441
Glioblastoma multiforme, 459
Glioma, 107
Goiter, 347
Gold(III) complexes, 361
Growth inhibition, 485
Growth, 419
GSK-3b, 193

Hamster, 25
Head & neck cancer, 157
Hepatocarcinogenesis, 121
Hepatocellular carcinoma, 59, 485
HLA-DR, 241
Hormonal therapy, 43
Hormone resistance, 43
HPMPC (cidofovir), 397
HT29 colon cancer cells, 343
Human interferon-g, 173
Human papillomavirus (HPV), 397
Humoral hypercalcemia of malignancy, 71
Hypericin, 409
Hypoxic cytotoxin(s), 185, 325

IL-6-null mice, 169
Immunohistochemistry, 203
Immunotherapy, 241
Inflammation, 409
Interferon-a2b, 241
Interleukin-8, 97, 241
Interleukin-13, 459
Interleukin-13 receptors, 459
Isobologram, 137
Isoforms, 451

KRN7000, 51

LAK cells, 371
Leukemia, 419
Liposome, 25
Lung cancer, 173
Lung cancer cell line, 335
Lung metastasis, 25
Lymphokine-activated killer cell, 17
Lymphoma, 315

Macrophages, 51
mdm2, 451
MDP-Lys, 25
Melanoma, 149, 241
Mesenchymal chondrosarcoma, 5
Metallotioneins, 169
Metastases, 181, 409
Methotrexate, 11
Mitogen-activated protein kinase, 485
MRP1, 219
Multitargeted antifolate, 231
Murine tumor model, 501
Mutant p53, 71
Mutation, 157
Myelocytic leukemia cell lines, 11

Necrotic-like cell death, 371
Neoplasia, 347
N-Nitrosomorpholine, 121
NK-92, 17
NK cells, 51, 209
NKT cells, 51
NLCQ-1, 185, 325
Novobiocin, 113
Nuclear factor-kB, 383
Nuclear localization, 491

Osteosarcoma, 25
Ovarian cancer, 97
 
 

 

p16CDKN2A tumor suppressor gene, 5
p16INK4A, 335
p53, 33, 43, 149, 203, 451
Parathyroid hormone-related protein (PTHrP), 71, 209
PCR-SSCP, 459
Pediatric, 451
P-glycoprotein, 219, 315
Photodynamic therapy, 409
Platelet-derived endothelial cell growth factor (PD-ECGF), 33
PMA, 419
Polymorphism, 149
Prodrug-converting enzyme, 127
Prognosis, 43, 107
Promoter hypermethylation, 491
Prostaglandin A1, 383
Prostate cancer, 43
Protein isoprenylation, 429
PSC 833, 315

13q14, 491

Radiation, 149
Radiosensitizers, 325
Ralitrexed, 137
ras, 477
Receptor, 157
RET/PTC3 oncogene, 347
Rhabdomyosarcoma, 451
RT-PCR, 409

Salmonella, 127
Salmonella typhimurium, 501
SCID mice, 209
Short-chain fatty acid, 83
Single-strand conformation analysis (SSCP), 149
Smad, 157
Small-cell lung cancer, 209
Sodium butyrate, 83
Soluble fiber, 83
Spontaneous lung metastasis, 121
Squamous cell carcinoma, 71, 157
Stress, 383

T98G, 17
Targeting, 127
Thymidine phosphorylase, 33
Thymidylate synthase, 309
Thyroid, 347
Tight junction, 469
Tirapazamine, 325
T lymphocytes, 315
Topoisomerase II, 113
Topotecan, 355
TPA, 419
Transforming growth factor-b, 157
Tumor-bearing mice, 169
Tumorigenesis, 347
Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL), 17
Tumor regressions, 477
Tumor suppressor gene(s), 441, 491

U373MG, 17

Vascular endothelial growth factor, 241
Vector, 127
VEGF, 33, 335
VNP20009, 501
VP-16, 113

Weak DNA intercalation, 185
Wilms' tumor, 441
Wnt/wingless signaling pathway, 469
WT1, 441

Xenograft, 477